The authors of A different paper described the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven].Youn et al. [fifty four] highlighted The shortage of consensus in dealing with CRAO via a national survey in America. The review s